by santereshealth | Feb 9, 2021 | CMP News
The Draft Screening Assessment for Protein Derivatives and Yeast Extract was published for a 60-day public comment period ending on April 7, 2021. Available here.
by santereshealth | Feb 9, 2021 | CMP News
The Final Screening Assessment for Dinoseb was published. A proposed risk management approach was also published for a 60-day public comment period ending on April 7, 2021. Available here
by santereshealth | Feb 9, 2021 | CMP News
The Final Screening Assessment for Benzophenone was published. A proposed risk management approach was also published for a 60-day public comment period ending on March 31, 2021. Available here.
by santereshealth | Feb 9, 2021 | CMP News
The draft screening assessment and risk management scope for the Decenes Group was published for a 60-day public comment period ending on March 10, 2021. Available Here.
by santereshealth | Feb 9, 2021 | CMP News
A notice of intent to amend the Domestic Substances List to apply the Significant New Activity (SNAc) provisions of the Canadian Environmental Protection Act, 1999 to trixylyl phosphate was published for a 60-day public comment period ending on February 17, 2021....
by santereshealth | Feb 9, 2021 | CMP News
The Draft Screening Assessment for Na3NTA was published for a public comment period ending on February 17, 2001. Available here.
Recent Comments